Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




A PALB2 Mutation Associated With High Risk of Breast Cancer
Link ID 33723
Title A PALB2 Mutation Associated With High Risk of Breast Cancer
Url http://www.medscape.com/viewarticle/737290?src=rss
Description Is targeted clinical testing of high-risk mutations justified? Breast Cancer Research
Category Articles > Hematology-Oncology
Keywords
Date Feb 23, 2011
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. CML Patients on Imatinib Live as Long as General Population
  Patients with chronic myelogenous leukemia (CML) treated with imatinib who remain in complete cytogenetic remission for 2 years have survival rates comparable to the general population. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. A Comparison of Stress Factors in Home and Inpatient Hospice Nurses
  Perceived stress factors and their correlation to perceived self-efficacy for inpatient versus home hospice nurses are reviewed. Which work setting is more stressful for nurses? Journal of Hospice and Palliative Nursing
Category:   Articles > Hematology-Oncology


3. Risk Factors, Prophylaxis, and Treatment of Venous Thromboembolism in Patients With Cancer
  Patients with cancer are at risk for venous thromboembolism, which can complicate care and increase mortality, but effective approaches are available to prevent or treat the problem. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


4. Cancer Treatment Strategies Target Epigenetic Alterations in Tumor Cells
  DNA demethylating agents and histone deacetylase inhibitors may reverse epigenetic changes in cancer cells. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. Urine Biomarker Test More Accurate in Detecting Prostate Cancer Than PSA
  A combination of 4 novel urine biomarkers achieved a specificity and positive predictive value for prostate cancer that was more accurate than the PSA and the PCA3. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS